| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Neurosciences, NIA, National Institutes of Health, Bethesda, MD.
We determined the rates of lateral ventricular enlargement and decline in cognitive performance for 11 men and nine women with dementia of the Alzheimer type (DAT), and compared these rates with the same measures obtained for age-matched healthy controls (nine men and eight women). DAT patients, as a group, had only mild cognitive impairment at initial evaluation, and each patient was followed from 9 months to over 7 years with yearly evaluations. Six DAT patients had isolated memory impairment as their only cognitive deficit early in the course of the disease. The rate of total lateral ventricle enlargement (cm3/yr) was significantly different between DAT and healthy controls, and was more specific and sensitive to the diagnosis of DAT than comparison of cross-sectional volumes at final evaluation. The rate of total lateral ventricular enlargement did not differ significantly by patient sex, ventricular size at initial evaluation, age, or degree of cognitive impairment as measured by Mini Mental State Examination scores. However, in the six DAT patients initially found to have isolated memory impairment, the rate of ventricular enlargement during the period of isolated memory impairment was significantly less than the rate of ventricular enlargement after the onset of nonmemory cognitive impairment. The diagnostic power of total lateral ventricular measures made from two CTs separated by 1 year and obtained early in the course of the illness, however, was only 0.33. We conclude that the total lateral ventricular enlargement accompanying DAT is due to continuous, pathologic cell loss, significantly greater than cell loss due to the healthy aging process. The rate of total lateral ventricular enlargement very early in the course of Alzheimer's disease is significantly less than the rate of ventricular enlargement is after the onset of nonmemory cognitive deficits but is stable for all other degrees of dementia severity, suggesting a biphasic process. Although not diagnostic for the disease early in its course, longitudinal CT measures can still provide a reliable and independent measure of disease progression in patients with DAT.
Address correspondence and reprint requests to Dr. Charles DeCarli, Laboratory of Neurosciences, NIA, Building 10, Room 6C414, National Institutes of Health, Bethesda, MTI 20892.
Received December 27, 1991. Accepted for publication in final form March 20, 1992.
This article has been cited by other articles:
|
|
 |
|
  J. M. Schott, S. L. Price, C. Frost, J. L. Whitwell, M. N. Rossor, and N. C. Fox Measuring atrophy in Alzheimer disease: A serial MRI study over 6 and 12 months Neurology, July 12, 2005; 65(1): 119 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr., M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. O'Brien, R. Cha, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD Neurology, January 28, 2003; 60(2): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K M Bradley, G M Bydder, M M Budge, J V Hajnal, S J White, B D Ripley, and A D Smith Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease Br. J. Radiol., June 1, 2002; 75(894): 506 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Scahill, J. M. Schott, J. M. Stevens, M. N. Rossor, and N. C. Fox Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI PNAS, April 2, 2002; 99(7): 4703 - 4707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G B FRISONI Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 711 - 718. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. W. Bokde, P. Pietrini, V. Ibanez, M. L. Furey, G. E. Alexander, N. R. Graff-Radford, S. I. Rapoport, M. B. Schapiro, and B. Horwitz The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease Arch Neurol, March 1, 2001; 58(3): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr., R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. G. Tangalos, and E. Kokmen Rates of hippocampal atrophy correlate with change in clinical status in aging and AD Neurology, August 22, 2000; 55(4): 484 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Resnick, A. F. Goldszal, C. Davatzikos, S. Golski, M. A. Kraut, E. J. Metter, R. N. Bryan, and A. B. Zonderman One-year Age Changes in MRI Brain Volumes in Older Adults Cereb Cortex, May 1, 2000; 10(5): 464 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Fox, S. Cousens, R. Scahill, R. J. Harvey, and M. N. Rossor Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease: Power Calculations and Estimates of Sample Size to Detect Treatment Effects Arch Neurol, March 1, 2000; 57(3): 339 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Fox, R. I. Scahill, W. R. Crum, and M. N. Rossor Correlation between rates of brain atrophy and cognitive decline in AD Neurology, May 1, 1999; 52(8): 1687 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Meyer, K. Muramatsu, K. F. Mortel, K. Obara, and T. Shirai Prospective CT Confirms Differences Between Vascular and Alzheimer's Dementia Stroke, May 1, 1995; 26(5): 735 - 742. [Abstract] [Full Text]
|
|
|
|
|
|
P. K. Shear, E. V. Sullivan, D. H. Mathalon, K. O. Lim, L. F. Davis, J. A. Yesavage, J. R. Tinklenberg, and A. Pfefferbaum Longitudinal Volumetric Computed Tomographic Analysis of Regional Brain Changes in Normal Aging and Alzheimer's Disease Arch Neurol, April 1, 1995; 52(4): 392 - 402. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
